As of 2025-09-17, the Fair Value of Kymera Therapeutics Inc (KYMR) is -19.26 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 48.78 USD, the upside of Kymera Therapeutics Inc is -139.49%.
With the market price of 48.78 USD and our fair value calculation, Kymera Therapeutics Inc (KYMR) is not a good investment. Investing in KYMR stocks now will result in a potential loss of 139.49%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 5Y Avg | |
| Net income | -45.59 | -100.22 | -154.81 | -146.96 | -223.86 | -134.29 |
| YoY growth | -10.52% | -119.83% | -54.47% | 5.07% | -52.32% | -46.41% |
| Market Cap (mil) | 3,487.77 |
| P/E | |
| Forward P/E |
| EPS | -3.85 |
| Avg earnings growth rate | -46.41% |
| TTM earnings | -275.43 |